Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Jun 2024 for Deciphera Pharmaceuticals, Inc..
Filing timeline
BuySaleFranklin Stuart Friedman
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Franklin Stuart Friedman: trading record in brief
Franklin Stuart Friedman discloses dealings in Deciphera Pharmaceuticals, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 8 June 2023 to 11 June 2024.
Every open-market trade on record is a purchase: 1 purchase worth €129k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 11 June 2024 with a transaction in Deciphera Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 1,230 days ago, on 12 June 2023. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Franklin Stuart Friedman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,000 sharesCommon StockSEC:0000950170-24-072218:0
10,000 shares@ US$13.8828100.0% of flowCommon StockSEC:0001209191-23-036244:0
Canonical exit: 6 Sept 2023 (T+90)
2 of 2 declarations
